> Visiting Washington/Alaska Chapter | Local links | End Visit > visit Canadian site

 

Live Help

View All Chapters

HOME
PATIENT SERVICES
DISEASE INFORMATION
HOW TO HELP
ADVOCACY
SCIENCE/PROFESSIONALS
LLS
About Us
Contact Us
Free eNews
Careers
Calendar
Press Room
News
About Us
Board & Staff Bios
eNewsletter Archives
Awards
SCOR Recipients
Our History
Email:
Password:
Remember Me
Not Yet Registered?



This website is certified by Health On the Net Foundation. Click to verify.
LLS
LLS > Press Room > News  print page
email this page
 $  Donate

Reuters
Balloon kyphoplasty effective for malignant spinal fractures
October 9, 2009 (Reuters Health) -

Last Updated: 2009-10-09 12:00:24 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Balloon kyphoplasty provides pain relief and functional improvement in patients with malignant spinal fractures, say researchers from Spain in the September 9th BMC Palliative Care.

Balloon kyphoplasty is performed percutaneously in an effort to relieve pain, restore vertebral height, and reduce biomechanical alterations of the spine caused by fractures, the authors explain.

Dr. Carmen Bouza and colleagues from Instituto de Salud Carlos III in Madrid performed a meta-analysis of 7 published reports describing the use of balloon kyphoplasty in 306 patients with malignant spinal fractures.

Treatment reduced mean pain scores both in the postoperative period and at the end of follow-up, the authors report.

Oswestry Disability Index scores showed a significant decrease in impairment and improvement in functional capacity after treatment in all 4 studies that measured it, and the improvements were sustained over the follow-up period.

Balloon kyphoplasty effectively improved the preexisting kyphotic deformity, the researchers note, reducing the absolute Cobb angle value and increasing the vertebral height.

There were 41 cement leakages associated with balloon kyphoplasty, representing approximately 6% of the levels treated, and the overall rate of new fractures was close to 10% (12.4% in patients with myeloma; 7.9% in patients with metastasis).

There were no deaths within 30 days of balloon kyphoplasty, the investigators say, although a small number of patients experienced clinical complications.

"Mention should be made (of) the fact that, at this time, there is an evident lack of studies comparing balloon kyphoplasty with other interventions, both invasive and noninvasive," the authors add. Two studies did compare kyphoplasty with vertebroplasty, and in these two, pain relief was similar but balloon kyphoplasty was associated with a lower cement leakage rate.

BMC Palliative Care 2009;8:12.



Copyright © 2010 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

back to top

The Leukemia & Lymphoma SocietyŽ (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.
Need Help? Contact us by email, mail, or call (800) 955-4572 copyright | disclaimer | link | privacy | security
spanish french portuguese